479 third-party lab reports publishedVolume pricing on every peptide, applied automatically in the cart: 3% off 2–3 · 8% off 4–5 · 12% off 6–7 · 15% off 8–9 · 20% off 10–19 · 25% off 20–29 · 30% off 30–39 · 35% off 40+ units · solvents and lab supplies excluded99.65% median purity across 272 lots257 / 257 lots pass sterility479 third-party lab reports publishedVolume pricing on every peptide, applied automatically in the cart: 3% off 2–3 · 8% off 4–5 · 12% off 6–7 · 15% off 8–9 · 20% off 10–19 · 25% off 20–29 · 30% off 30–39 · 35% off 40+ units · solvents and lab supplies excluded99.65% median purity across 272 lots257 / 257 lots pass sterility
Batch 1723 · tested July 28, 2026 (99 days ago) · released August 26, 2026
All tests passed
Batch
#1723 14 of 15 tests
Mass
5mg each (10mg total)
Purity
>99.50%
Issuing lab accreditation
Vanguard · ISO 17025:2017 / A2LA #6377.01.01
3 units tested for purity, each printed >99.50% · net peptide content · ipamorelin 5.85 / 5.91 / 5.92 mg · net peptide content · cjc-1295 5.52 / 5.59 / 5.6 mg
Conformity: Units agree — every reported unit passed on all 13 test rows · purity spread at most 0.50 pt within the house limit · content spread (Ipamorelin) 1.2% within the house limit · content spread (CJC-1295) 1.4% within the house limit · QA approval corroborates: Vanguard Laboratory, Tori Johnson, Operations Manager, 2026-07-28
Revalidated 8 Sep 2026: product corrected from CJC-1295 No DAC to the CJC/Ipamorelin blend to match the PDF (compound 'CJC-1295 no DAC/Ipamorelin') and submission #63644.
Content audit 9 Sep 2026: size all sizes → #686 5mg-each-10mg-total. Certificate prints: prints compound "CJC-1295 no DAC/Ipamorelin", lot "1723", lab id "V260709-5 004", content Ipamorelin 5.85/5.91/5.92 mg; CJC-1295 5
13 results on the report · 4 rows computed from the per-unit values · 2 labs · each test used up to 5 vials from this lot (rows are not added together) · every row names the chapter or house rule it follows
✓IdentityPass
1 of 1 pass · 1 unit · USP <621> (procedural chapter)
✓PurityPass
3 of 3 pass · 3 units · USP <621> (procedural chapter)
✓Purity consistency between unitsWithin house limit
3 units, each above 99.50% (the lab's reporting bound) · units differ by at most 0.50 pt · house limit · caution past 0.50 pt, outside past 1.00 pt · per-unit USP <621> results
✓Content consistency between units · IpamorelinWithin house limit
3 units: 5.85 / 5.91 / 5.92 mg · spread 0.07 mg, 1.2% of the mean · house check · caution past 5%, outside past 10% · USP <905> is the compendial reference for between-unit uniformity (10 units; not claimable on 3)
✓Content consistency between units · CJC-1295Within house limit
3 units: 5.52 / 5.59 / 5.6 mg · spread 0.08 mg, 1.4% of the mean · house check · caution past 5%, outside past 10% · USP <905> is the compendial reference for between-unit uniformity (10 units; not claimable on 3)
✓Heavy metalsWithin limits
5 elements non-detect · 2 units · dose-scaled limits derived from USP <232> (limits chapter)
Element
Measured
Limit
Verdict
Chromium (Cr)
ND (<0.05 ppm)
1,100,000 ppm
Not detected
Arsenic (As)
ND (<0.01 ppm)
15,000 ppm
Not detected
Cadmium (Cd)
ND (<0.01 ppm)
2,000 ppm
Not detected
Lead (Pb)
ND (<0.02 ppm)
5,000 ppm
Not detected
Mercury (Hg)
ND (<0.01 ppm)
3,000 ppm
Not detected
Dose-scaled limits derived from USP <232> for arsenic, cadmium, lead, mercury and chromium, using this product's configured reference quantity of 1.00 mg.
✓Residual solventsWithin limits
all non-detect · 1 unit · USP <467> (procedural chapter)
✓Trifluoroacetic acidWithin limits
all non-detect · 1 unit · house limit · ion chromatography, the lab's method; no compendial chapter for the method run · limit <0.10% (the lab's)
✓EndotoxinsPass
3 of 3 pass · 3 units · USP <85> (procedural chapter) · limit <5.00 EU/mg (the lab's)
✓Container closurePass
3 of 3 pass · 3 units · USP <1207> (informational chapter (1000-series))
✓SolubilityPass
3 of 3 pass · 3 units · house check · no compendial chapter
✓SterilityPass
5 of 5 pass · 5 units · USP <71> (procedural chapter)
✓SterilityPass
1 of 1 pass · 1 unit · USP <71> (reference) · a rapid viability test used as an alternative to the USP <71> growth test; USP <1223> is the validation framework (informational chapter) · at Eagle Analytical
✓Other · Adulterant screenWithin limits
all non-detect · 1 unit · no chapter named in the record; a screen
✓ConformityUnits agree
every reported unit passed on all 13 test rows · purity spread at most 0.50 pt within the house limit · content spread (Ipamorelin) 1.2% within the house limit · content spread (CJC-1295) 1.4% within the house limit · QA approval corroborates: Vanguard Laboratory, Tori Johnson, Operations Manager, 2026-07-28 · house check · agreement across all tests, unit to unit; QA approval corroborates
A chapter number names the method or limit a result follows; it does not describe the product. Chapters below 1000 are procedures or limits; 1000-series chapters are informational. USP <905> is the compendial test for between-unit uniformity: it assays 10 units, so a 3-unit certificate cannot yield its acceptance value — the content row is a house check with <905> named as the reference only.
Combined report · Batch 1723
One file holding the Vanguard Laboratory and Eagle Analytical Services reports for this batch, combined by our system from the labs' own files.
